Peripheral vasodilator responsiveness was examined in pacing-induced heart failure (HF) in 11 conscious dogs chronically instrumented for measurement of systemic (total peripheral resistance [TPR] 
It is generally acknowledged that heart failure (HF) is characterized by ,B-adrenergic receptor desensitization in the myocardium, as manifested by depressed inotropic responses to ,B-adrenergic agonists, [1] [2] [3] [4] and is associated with several abnormalities in /-adrenergic receptor signaling.'-1" Since the trigger for /3-adrenergic receptor desensitization is thought to be chronically elevated circulating catecholamines,12-15 this condition should also induce desensitization of peripheral 3-adrenergic receptors as well as those in the heart. However, prior studies investigating this problem have generally not confirmed peripheral /3-adrenergic receptor desensitization; eg, Creager et al16 found no difference in forearm blood flow response to isoproterenol studies'6'7: (1) Chronic studies in humans and acute studies in animals, by design, cannot be conducted in the same experimental subjects before and after HF, which limits the statistical power of those investigations. (2) Prior animal studies have been conducted in anesthetized or isolated preparations, in which the effects of the anesthetic and surgical preparation can potentially be greater than the intervention to be studied.
To address these concerns, the experimental design of the current investigation used the same animals studied in the conscious state before and after the induction of HF. An additional potential confounding influence is the role of autonomic reflexes, which modulate the effects of systemically administered vasodilators. The current investigation addressed this issue by using two approaches. The first approach was to examine systemically administered vasodilators in the presence and absence of ganglionic blockade. The second approach was to examine the effects of local intra-arterial injections, which did not elicit systemic responses and consequent reflex buffering. Another potential confounding influence is the role of endothelium-derived relaxing factor (EDRF), which has generally been thought to be altered in HF,18-23 although not consistently.24 '25 To address this potential problem, the vasodilators were also examined in the presence and absence of nitro-L-arginine, a competitive inhibitor of nitric oxide synthase. Finally, the mechanism of altered ,3-adrenergic receptor responsiveness was examined in vitro using f3-adrenergic receptor antagonist binding in sarcolemmal membrane preparations from mesenteric arterial vessels. The arterial vessels in the mesentery were selected for this analysis, since these include resistance vessels.
We used three different vasodilators (ISO, acetylcholine [ACh] , and nitroglycerin [NTG] ) to study the impaired vascular responsiveness in HF. ISO causes vasodilation by direct interaction with /3-adrenergic receptors on vascular smooth muscle. These direct effects are buffered by arterial baroreflex mechanisms in conscious animals, necessitating examination under ganglionic blockade to unmask direct effects. Furthermore, a component of the vasodilation induced by ISO is due to flow-mediated vasodilation, which is mediated by endothelium-dependent mechanisms and necessitates examination in the presence of nitric oxide synthase inhibitors. Thus, selective and combined blockades allow for isolation of the direct B-adrenergic effects. These physiological responses were further complemented by biochemical studies of f3-adrenergic receptor density and affinity in mesenteric artery preparations. ACh is the classic endothelium-dependent vasodilator,26 which stimulates the release of nitric oxide from endothelial cells, resulting in smooth muscle relaxation. NTG, on the other hand, is converted nonenzymatically into nitric oxide and is therefore a direct test of vascular smooth muscle responsiveness, independent of receptor or endothelium-dependent mechanisms. The integrity of the response to NTG ensures that the vascular smooth muscle has not been altered structurally to a significant degree.
Materials and Methods

Preparation of the Model
Adult mongrel dogs of either sex were anesthetized with halothane (0.5 to 1.5 vol/100 mL in oxygen) and ventilated with a Harvard respirator after induction with thiamylal sodium (10 to 15 mg/kg IV). A left thoracotomy was performed through the fifth intercostal space using sterile technique. Tygon catheters (Norton Co, Akron, Ohio) were placed in the descending thoracic aorta and right atrium, and a solid-state pressure gauge (model P22, Konigsberg Instruments, Inc, Pasadena, Calif) was inserted into the left ventricle (LV) via an apical stab wound. An aortic flow probe (Transonic Systems, Ithaca, NY) was implanted around the root of the ascending aorta to measure ascending aortic flow (cardiac output). Stainless-steel pacing wires were placed on the right ventricle. The chest incision was closed in layers, and the thorax was evacuated of air. An abdominal midline incision was then performed using sterile technique, through which a Tygon catheter was placed in the lower abdominal aorta and a Doppler flow probe was implanted around the iliac artery. All animals were allowed to recover for 2 to 3 weeks before experimentation. The animals used in this study were 
Results
Hemodynamic Effects of HF Table 1 illustrates the changes in LV and systemic hemodynamics after the development of advanced HF compared with control measurements in the same dogs. Heart rate rose from 89+4 to 132±6 beats per minute, right atrial pressure rose from 0.5 ±0.2 to 9.2±0.5 mm Hg, and LV end-diastolic pressure rose from 6.7 ±0.4 to 28.0± 1.5 mm Hg, whereas mean arterial pressure fell from 95±2 to 80+2 mm Hg, LV dP/dt fell from 2858±71 to 1326±76 mm Hg/s, cardiac output fell from 2.5±0.2 to 1.7±0.1 L/min, and iliac blood flow fell from 110±7 to 96±4 mL/min. However, baseline TPR was not increased significantly from a control value of 39 Effects of ISO, ACh, and NTG Before and After HF (Fig 1) Peripheral vascular responsiveness to ISO ( (Fig 2) In the presence of ganglionic blockade, peripheral vascular responsiveness to ISO ( 
Effects of Inhibition of Nitric Oxide Synthase on
Baseline Hemodynamics (Fig 3) In four dogs, the effects of inhibition of nitric oxide synthase in the presence of ganglionic blockade resulted in increases in mean arterial pressure (+89±16%) and TPR (+ 154±28%). After by profound f8-adrenergic receptor desensitization in the myocardium, in terms of depressed inotropic responsiveness to f,-adrenergic agonists,1-4 which is mediated by several disorders in 13-adrenergic receptor signaling.1-11 Similar abnormalities have also been observed in the model of pacing-induced HF. The model is characterized by severe contractile dysfunction and ventricular dilatation and eventual impairment in cardiac output. There is also evidence of neurohumoral activation and myocardial catecholamine depletion.7 In addition, abnormal myocardial ,3-adrenergic signal transduction is characterized by selective 131-receptor downregulation, a marked decrease in the number of receptors binding agonist with high affinity, depression of the adenylyl cyclase catalytic unit, and increases in the inhibitory G proteins without a change in the amount or activity of the stimulatory G proteins.5-7 In aggregate, these findings mediate depressed myocardial inotropic response to ,B-adrenergic stimulation. This was confirmed in the present investigation demonstrating an 80+6% decrease in inotropic response to ISO, as reflected by LV dP/dt measurements. It must be kept in mind that the positive inotropic response to ISO reflects the combined direct effect of f8-adrenergic receptor stimulation on the myocardium and the additional boost of reflex increases in inotropy. The current investigation demonstrates for the first time that the inotropic response to ISO was still markedly depressed (by 57+±7%) for mean+SEM changes in percent total peripheral resistance (TPR) are shown for injections of isoproterenol (ISO, left), acetylcholine (ACH, middle), and nitroglycerin (NTG, right) in the presence of ganglionic blockade plus inhibition of nitric oxide synthase before (o) and after heart failure (0). After heart failure, there were significant (P<.05) differences in the regression lines in response to ISO, indicating that the peripheral vascular responsiveness to ISO was attenuated after heart failure. In contrast, the peripheral vascular responsiveness to ACH It is not difficult to perceive how interindividual variability might obscure the differences observed in the current investigation. It could be argued that altered reflex mechanisms in HF could complicate the interpretation of studies in intact conscious animals. Indeed, it is well known that HF impairs baroreceptor control of heart rate.35-37 By reducing arterial pressure, ISO elicits baroreflex-mediated tachycardia and peripheral vasoconstriction. Since it would be anticipated that these reflex effects were impaired in HF, it might be expected that depressed responses to ISO would not be easily observed in HF; FIG 5 . Log dose-response curves for mean+SEM changes in percent iliac blood flow are shown for local injections of isoproterenol (ISO, left), acetylcholine (ACH, middle), and nitroglycerin (NTG, right) before (o) and after heart failure (-). After heart failure, there were significant (P<.05) differences in the regression lines in response to ISO and ACH, indicating that the percent increases in iliac blood flow to ISO and ACH, but not to NTG, were attenuated after heart failure. To examine this further at the in vitro level, sarcolemmal membranes were prepared from mesenteric vessels, and ,B-adrenergic receptor density was examined with '251-cyanopindolol binding and Scatchard analyses. These experiments demonstrated significantly decreased ,3-adrenergic receptor density, roughly corresponding to the depressed physiological responsiveness observed. Interestingly, Frey et a117 also noted 83-adrenergic receptor downregulation in skeletal muscle, and as noted above, numerous studies have demonstrated ,B-adrenergic receptor downregulation in the heart.'1-" It is also conceivable that other distal mechanisms involved in 83-adrenergic signaling were also abnormal in vascular smooth muscle in HF, as they are in the heart.'1-" One potential difference between prior studies in myocardial /3-adrenergic receptor downregulation and the present study is that the predominant ,B-adrenergic receptor subtype in the heart is 13,, whereas the predominant subtype peripherally is ,32. in the present study. It is likely that the chronically elevated levels of plasma norepinephrine and epinephrine may have mediated the peripheral ,B-adrenergic receptor desensitization that was observed.
In summary, the peripheral vascular responsiveness to endothelium-and ,B-adrenergic receptor-mediated relaxation was attenuated in conscious dogs with pacing-induced HF. The combined effects of alteration in these two mechanisms could have a significant impact on peripheral vasodilator capacity and regulation of regional blood flow in HF. The depressed peripheral vascular responsiveness to 3-adrenergic receptor stimulation is neither mediated by altered reflex nor endothelial control but rather by downregulation of vascular /3-adrenergic receptor mechanisms.
